ArticleMolecular oncology2017

The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.

Karen Hanrahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.